Rosmarinic Acid‐Treated Exosomes Modulate <scp>TGF</scp> ‐β1/Smad3 Signaling to Alleviate Cardiac Fibrosis in an In Vitro/In Vivo Model

Cardiac fibrosis (CF) is a major complication of myocardial infarction (MI), impairing myocardial function and leading to heart failure. Rosmarinic acid (RA) exhibits cardioprotective and antifibrotic properties, representing a promising therapeutic strategy for CF. This study evaluated the efficacy of exosomes derived from RA-primed adipose-derived stem cells (ADSCs), focusing on how RA-priming enhances their antioxidant and antifibrotic capacity against CF. An Isoproterenol (ISO)-induced myocardial injury model was established in vitro and in vivo. In vitro, H9C2 cardiomyoblasts were first injured with ISO and then treated with either exosomes (Exo) or RA-primed exosomes (RA-MSC-Exo) to assess cell viability and apoptosis. In vivo, 48 Wistar rats were divided into six groups: Control, Exo, RA-MSC-Exo, ISO, ISO + Exo, and ISO + RA-MSC-Exo. We assessed cardiac biomarkers (CK-MB and troponin I), reactive oxygen species (ROS), and total antioxidant capacity (TAC). We performed echocardiographic, molecular (real-time PCR and Western blotting), and histological analyses (Masson's trichrome staining) to evaluate cardiac function, fibrosis signaling pathways (NF-κB, TGF-β1, SMAD3), and collagen deposition. In vitro, both Exo and RA-MSC-Exo treatments significantly restored cell viability and reduced apoptosis in ISO-injured H9C2 cells. In vivo, both treatments significantly mitigated ISO-induced cardiac injury by reducing cardiac biomarkers, decreasing ROS production, and enhancing TAC levels. These interventions downregulated the expression of NF-κB, TGF-β1, Smad3, and Collagen I, leading to attenuated collagen deposition and improved cardiac function. Our study demonstrates that RA-primed exosomes effectively mitigate CF and improve cardiac function in an ISO-induced myocardial ischemia model. This targeted approach offers a promising therapeutic strategy for managing myocardial injury and its fibrotic complications.

Authors

Institutions

Publication Details

Journal
The FASEB Journal
Published
2026-02-03
DOI
https://doi.org/10.1096/fj.202501842rr
Primary Topic
Cardiac Fibrosis and Remodeling
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Rosmarinic Acid‐Treated Exosomes Modulate TGF ‐β1/Smad3 Signaling to Alleviate Cardiac Fibrosis in an In Vitro/In Vivo Model

Mahin Dianat, Ali Asadirad, Zahra Mansouri, Seyyed Ali Mard et al.
The FASEB Journal
Cardiac Fibrosis and Remodeling
article

Rosmarinic Acid‐Treated Exosomes Modulate TGF ‐β1/Smad3 Signaling to Alleviate Cardiac Fibrosis in an In Vitro/In Vivo Model

Mahin Dianat, Ali Asadirad, Zahra Mansouri, Seyyed Ali Mard, Nehzat Akiash, Mohammad Badavi
article en

Abstract

Cardiac fibrosis (CF) is a major complication of myocardial infarction (MI), impairing myocardial function and leading to heart failure. Rosmarinic acid (RA) exhibits cardioprotective and antifibrotic properties, representing a promising therapeutic strategy for CF. This study evaluated the efficacy of exosomes derived from RA-primed adipose-derived stem cells (ADSCs), focusing on how RA-priming enhances their antioxidant and antifibrotic capacity against CF. An Isoproterenol (ISO)-induced myocardial injury model was established in vitro and in vivo. In vitro, H9C2 cardiomyoblasts were first injured with ISO and then treated with either exosomes (Exo) or RA-primed exosomes (RA-MSC-Exo) to assess cell viability and apoptosis. In vivo, 48 Wistar rats were divided into six groups: Control, Exo, RA-MSC-Exo, ISO, ISO + Exo, and ISO + RA-MSC-Exo. We assessed cardiac biomarkers (CK-MB and troponin I), reactive oxygen species (ROS), and total antioxidant capacity (TAC). We performed echocardiographic, molecular (real-time PCR and Western blotting), and histological analyses (Masson's trichrome staining) to evaluate cardiac function, fibrosis signaling pathways (NF-κB, TGF-β1, SMAD3), and collagen deposition. In vitro, both Exo and RA-MSC-Exo treatments significantly restored cell viability and reduced apoptosis in ISO-injured H9C2 cells. In vivo, both treatments significantly mitigated ISO-induced cardiac injury by reducing cardiac biomarkers, decreasing ROS production, and enhancing TAC levels. These interventions downregulated the expression of NF-κB, TGF-β1, Smad3, and Collagen I, leading to attenuated collagen deposition and improved cardiac function. Our study demonstrates that RA-primed exosomes effectively mitigate CF and improve cardiac function in an ISO-induced myocardial ischemia model. This targeted approach offers a promising therapeutic strategy for managing myocardial injury and its fibrotic complications.

The FASEB JournalVol. 40(3)
Ahvaz Jundishapur University of Medical Sciences (IR)
Aromatic Plant Research Center, Ahvaz Jundishapur University of Medical Sciences
Good health and well-being
Openalex Percentile: Top 69%
Cardiac Fibrosis and Remodeling
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.